Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Cytosorbents Corp

NASDAQ: CTSO · Industrial Applications and Services · 5 alerts · CIK 1175151

Share price
$4.85Close, Nov 16
Market cap
$305M
Shares outstanding
62.84MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cytosorbents Corp filings on SEC EDGAR ↗

4:17 PM ET 8-K
Financial Results

Cytosorbents Financial Results

CytoSorbents reported Q3 2026 financial results, highlighting the achievement of operating cash flow breakeven (excluding restructuring payments). Revenue grew 3% to $9.7 million, while operating loss improved by 59% to $1.2 million due to disciplined cost management and improved gross margins.

Term
Q3 2026

“The third quarter marked an important financial milestone for CytoSorbents as we achieved our goal of operating cash flow breakeven, excluding restructuring-related payments. This achievement reflects a year of disciplined execution and meaningful improvements in our underlying business.”

Dr. Phillip Chan, Chief Executive Officer
7:31 AM ET 8-K
Nasdaq/NYSE Compliance Notice

Cytosorbents Nasdaq/NYSE Compliance Notice

CytoSorbents has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its stock closed at or above that level for 10 consecutive trading sessions. However, the company remains non-compliant with the $35 million Minimum Market Value of Listed Securities (MVLS) requirement and has until December 28, 2026, to resolve this deficiency.

Counterparty
Nasdaq
Term
until Dec 28, 2026
5:31 PM ET Form 4
Insider Buying

Cytosorbents CEO Phillip P. Chan Buys $22.6K of Stock

Phillip P. Chan, CEO, bought 3,774 shares of Cytosorbents Corp at $6.00 a share, worth $22.6K in total on Sep 15, 2026. Shares held after the trade: 100,996 (+3.9%).

Value
$22.6K
Shares
3,774
Price
$6.00
Role
CEO
Holding change
+3.9%
Trade date
Sep 15, 2026
4:06 PM ET Form 4
Insider Buying

Cytosorbents President and COO Vincent Capponi Buys $10.9K of Stock

Vincent Capponi, President and COO, bought 1,800 shares of Cytosorbents Corp at $6.07 a share, worth $10.9K in total on Sep 14, 2026. Shares held after the trade: 40,114 (+4.7%).

Value
$10.9K
Shares
1,800
Price
$6.07
Role
President and COO
Holding change
+4.7%
Trade date
Sep 14, 2026
4:05 PM ET Form 4
Insider Buying

Cytosorbents Insider Alan D. Sobel Buys $11.6K of Stock

Alan D. Sobel bought 1,900 shares of Cytosorbents Corp at $6.12 a share, worth $11.6K in total on Sep 15, 2026. Shares held after the trade: 9,287 (+25.7%).

Value
$11.6K
Shares
1,900
Price
$6.12
Holding change
+25.7%
Trade date
Sep 15, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.